![\"diabesity](\"https:\/\/dibesity.com\/wp-content\/uploads\/2021\/06\/diabesity-dibesity-758x624.webp\")
<\/figure>\n\n\n\nDiabesity or Dibesity<\/strong> is a new term derived from two words, \u201cDia<\/strong>\u201d for Diabetes and \u201cBesity<\/strong>\u201d for Obesity. It is the occurrence of Diabetes in Obese individuals.<\/p>\n\n\n\n It is the combination of two global pandemics, diabetes, and obesity<\/strong>. Commonly used terms, phrases, or definitions used to elaborate on diabesity are:<\/p>\n\n\n\n Understanding diabesity is very important for the following reasons:<\/strong><\/p>\n\n\n\n \u201cRead: How to Prevent Yourself from Diabesity\u201d<\/a><\/strong><\/p>\n\n\n\n Metabolic syndrome<\/a>, also called syndrome X or Insulin resistance <\/strong>syndrome is defined as the occurrence of three or more of the following criteria in an individual (Ref: NCEP ATP3 2005 Criteria<\/a>):<\/p>\n\n\n\n It is important to note here that metabolic syndrome has five important parameters and obesity is not a prerequisite for the diagnosis of the syndrome. Any three of the criteria constitute the metabolic syndrome.<\/a><\/strong><\/p>\n\n\n\n Diabesity is diabetes in the context of obesity. Diabesity with one other cardiovascular risk factor constitutes metabolic syndrome.<\/p>\n\n\n\n Patients with metabolic syndrome<\/a> may neither be obese nor have diabetes. Hence, diabesity is a subset of metabolic syndrome. Both conditions are not synonymous.<\/p>\n\n\n\n Like Diabesity, Obesity and Metabolic abnormalities when present together are termed \u201cMetabesity<\/strong><\/a>\u201c. It is also a newer term and highlights the importance of metabolic problems that an obese person can face.<\/p>\n\n\n\n These may range from dyslipidemia to heart diseases, strokes, kidney disease, and hypertension.<\/p>\n\n\n\n Diabetes and obesity are very prevalent. Worldwide, 9.3% of adults have diabetes accounting for 463 million people worldwide.<\/p>\n\n\n\n The prevalence of obesity<\/a> in diabetic patients is estimated to be around. In 2016, 1.9 billion people were above the normal weight.<\/p>\n\n\n\n Out of these 1.9 billion people, 650 million people were obese. 39 million children under the age of five years were estimated to be obese in 2020.<\/p>\n\n\n\n Among children in the age groups of 5 \u2013 19 years, over 340 million children were obese in 2016. Among overweight individuals, the prevalence of diabetes is estimated to be around 30% and the prevalence of obesity in diabetic individuals is estimated to be around 85% [Ref<\/a>].<\/p>\n\n\n\n As the name suggests, diabesity is the occurrence of diabetes and obesity. The two most common symptoms of diabesity are obesity and high blood sugar.<\/p>\n\n\n\n All the symptoms of diabesity revolve around these two conditions and the complications arising from these two conditions.<\/p>\n\n\n\n So, if you are overweight or obese<\/a> and have symptoms of diabetes, you have diabesity. Symptoms of diabetes may range from subtle non-specific symptoms to classic symptoms of diabetes like:<\/p>\n\n\n\n Diabetes<\/strong> <\/a>is defined as :<\/p>\n\n\n\n Obesity<\/strong> has been defined in various ways. One way is the waist circumference as per the NCEP ATP3 2005 Criteria.<\/p>\n\n\n\n However, the most commonly used classification and criteria for defining obesity are based on the BMI (body mass index). BMI is calculated as (weight in Kgs\/ height in m2<\/sup>)<\/a>. The following classification is used according to the BMI:<\/p>\n\n\n\n This is further divided into three different classes based on the severity of the condition:<\/strong><\/p>\n\n\n\n It is important to note that the cut-offs for Asians are different. A BMI of 23 or more to less than 25 kg\/m2 <\/sup>is labeled as overweight and BMI exceeding 25 kg\/m2 <\/sup>is labeled as obesity.<\/p>\n\n\n\n Treatment of most metabolic conditions starts with lifestyle and dietary interventions. A brisk walk<\/a>, running, swimming, or cycling are among the best exercises to burn fats and calories.<\/p>\n\n\n\n This should be combined with a low-calorie diet. Diet high in fiber<\/a>, low in carbohydrates, and calories when combined with regular aerobic exercise<\/a> for 30 minutes or more constitutes the best practice for weight loss programs.<\/p>\n\n\n\n A long list of medications is available to treat diabetes. However, few medicines effectively treat obesity.<\/p>\n\n\n\n Since diabesity is diabetes occurring in the context of obesity, treating obesity effectively might cure diabetes in these patients.<\/p>\n\n\n\n Until now, most medications used to treat diabetes caused weight gain<\/a>. This would initiate the vicious cycle of weight gain, immobility, and hyperglycemia.<\/p>\n\n\n\n The paradigm has shifted recently to the novel class of medications like GLP-1 analogs<\/a> and SGLT-2 inhibitors<\/a>.<\/p>\n\n\n\n These medications effectively lower blood glucose while simultaneously resulting in weight loss. FDA has recently approved Wegovy<\/a> (a high-dose once-weekly injectable Semaglutide<\/a>) for the treatment of obesity.<\/p>\n\n\n\n Wegovy Comparison with Other Weight Loss Drugs<\/a><\/strong><\/p>\n<\/blockquote>\n\n\n\n It could prove an important milestone in the treatment of diabesity. Tirzepatide (Mounjaro)<\/a> is a dual GLP-1 and GIP analog and has been proven in clinical trials to be more effective than Wegovy or Ozempic (Semaglutide)<\/a>, and Trulicity (Dulaglutide)<\/a>. However, its approval as a weight-loss drug is currently pending.<\/p>\n\n\n\n Medications are commonly used for weight loss however, the best results are achieved with metabolic surgeries (previously called bariatric surgery<\/a>).<\/p>\n\n\n\n The gut is considered one of the major endocrine organs. The field of bariatric and metabolic surgery is evolving.<\/p>\n\n\n\n Surgeons have achieved dramatic results with bariatric surgeries.<\/p>\n\n\n\n Bariatric surgeries do not only result in weight loss but also improve most metabolic abnormalities including diabetes, hypertension, and dyslipidemias.<\/p>\n\n\n\n Diabesity is associated with serious complications. It is a two-pronged sword. The complications of diabetes are well-known.<\/p>\n\n\n\n It is the most common cause of end-stage renal disease, blindness, cardiovascular disease, and amputations.<\/p>\n\n\n\n Diabesity is a combination of two co-morbid conditions itself. Furthermore, it adds up to the complications associated with each condition. Thus patients are at very high risk of developing the following complications:<\/p>\n\n\n\n <\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":" Diabesity = Diabetes + Obesity by\u00a0Dr. Ahmed Diabesity or Dibesity is a new term derived from two words, \u201cDia\u201d for Diabetes and \u201cBesity\u201d for Obesity. It is the occurrence of Diabetes in Obese individuals. It is the combination of two global pandemics, diabetes, and obesity. Commonly used terms, phrases, or definitions used to elaborate on diabesity are:<\/p>\n\n
Why Understanding Diabesity is Important?<\/strong><\/h2>\n\n\n\n
\n
Are diabesity and Metabolic Syndrome Two Different Entities?<\/strong><\/h2>\n\n\n\n
\n
How Prevalent is Diabesity?<\/strong><\/h2>\n\n\n\n
What are the Symptoms of Diabesity?<\/strong><\/h2>\n\n\n\n
\n
What cut-offs are used to define diabesity?<\/strong><\/h2>\n\n\n\n
Diabetes:<\/strong><\/h3>\n\n\n\n
\n
Obesity<\/a>:<\/strong><\/h3>\n\n\n\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Ho to treat Diabesity?<\/strong><\/h2>\n\n\n\n
\n
What are the complications of diabesity?<\/strong><\/h2>\n\n\n\n
\n
\n